Results 1 to 10 of about 40,431 (264)

Histiocytosis

open access: yesThe Lancet, 2021
International ...
Emile, Jean-François   +8 more
openaire   +4 more sources

Histiocytosis-X [PDF]

open access: bronzeProceedings of the Royal Society of Medicine, 1962
J S Pegum, Patricia Wallis
openalex   +3 more sources

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

open access: yesBlood, 2022
Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary (smoking-associated), or multisystem disease.
G. Goyal   +17 more
semanticscholar   +1 more source

ALK+ histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

open access: yesBlood, 2021
ALK-related histiocytosis (formerly ALK-positive histiocytosis) is a rare subtype of histiocytic neoplasm first described in 2008 in three infants with multisystemic disease involving the liver and hematopoietic system.
P. Kemps   +80 more
semanticscholar   +1 more source

Progress in the diagnosis and treatment of ocular histiocytosis [PDF]

open access: yesGuoji Yanke Zazhi, 2023
Ocular histiocytosis is a rare and heterogeneous group of disorders which can occur in children and adults. There is a great challenge in the diagnosis and treatment because of the atypical clinical and imaging manifestations.
Jun-Yi Qiao, Wei-Min He
doaj   +1 more source

Langerhans cell histiocytosis in adults: literature review

open access: yesОнкогематология, 2022
Langerhans cells histiocytosis is a variant of malignant histiocytosis. The course and symptoms vary. patients with localized forms have a better prognosis, because local therapy is effective.
V. G. Potapenko   +3 more
doaj   +1 more source

Histiocytosis and the nervous system: from diagnosis to targeted therapies

open access: yesNeuro-Oncology, 2021
Histiocytoses are heterogeneous hematopoietic diseases characterized by the accumulation of CD68(+) cells with various admixed inflammatory infiltrates.
F. Cohen Aubart   +7 more
semanticscholar   +1 more source

Langerhans cell histiocytosis: Version 2021

open access: yesHematological Oncology, 2021
Children with Langerhnans cell histiocytosis (LCH) develop granulomatous lesions with characteristic clonal CD207+ dendritic cells that can arise as single lesions or life‐threatening disseminated disease. Despite the wide range of clinical presentations,
N. Gulati, C. Allen
semanticscholar   +1 more source

Establishment of MOS-SF36 percentile ranks in the general youth French population

open access: yesBMC Psychology, 2022
Background The SF-36 is a generic quality of life questionnaire, massively translated and widely used to obtain physical and mental health status. However, validation work in the French language was carried out over a generation ago.
Arthur Trognon   +4 more
doaj   +1 more source

Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis

open access: yesCell Communication and Signaling, 2022
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid malignancy in the “L-group” histiocytosis. Mitogen-activated protein kinase (MAPK) pathway activating mutations are detectable in nearly all LCH lesions. However, the pathogenic roles of MAPK
Xue-min Gao, Jian Li, Xin-xin Cao
doaj   +1 more source

Home - About - Disclaimer - Privacy